Delivering drugs to kidney via microbots

Precise drug targeting is essential to reduce adverse effects. 

The researchers show that a biohybrid microrobot based on picoeukaryotes, engineered as a cargo carrier for active delivery in tight in vivo spaces.

The microrobot was able achieve outstanding kidney penetration, uniform distribution, and >48- hour retention. Microboat also showed immune clearance and excellent biosafety.

Thus picoeukaryote-based biohybrid microrobot system represents a major advancement in active drug delivery, especially tailored to the challenging microenvironments of the kidney.

https://www.science.org/doi/10.1126/sciadv.adw8578

https://sciencemission.com/microrobots-for-active-delivery-in-the-kidney